Vassallo, C., Canali, B., Fiorentino, F., Morelli, P., Ripoli, S. and Fioravanti, L. (2023) “Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy”, AboutOpen, 10(1), pp. 103–109. doi: 10.33393/ao.2023.2609.